Free Trial

Molina Healthcare, Inc. (NYSE:MOH) Holdings Trimmed by MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH

Molina Healthcare logo with Medical background

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH lowered its stake in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 23.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,189 shares of the company's stock after selling 1,622 shares during the quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH's holdings in Molina Healthcare were worth $1,709,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the stock. Rothschild Investment LLC increased its holdings in shares of Molina Healthcare by 126.3% during the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after buying an additional 48 shares during the last quarter. Colonial Trust Co SC raised its holdings in shares of Molina Healthcare by 930.0% in the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company's stock worth $30,000 after purchasing an additional 93 shares during the period. Hurley Capital LLC acquired a new position in shares of Molina Healthcare in the 4th quarter valued at about $55,000. EverSource Wealth Advisors LLC grew its holdings in shares of Molina Healthcare by 81.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after purchasing an additional 88 shares during the period. Finally, Harvest Fund Management Co. Ltd increased its position in Molina Healthcare by 895.0% during the 4th quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company's stock worth $58,000 after purchasing an additional 179 shares in the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Molina Healthcare Stock Performance

Shares of NYSE MOH traded down $7.97 during trading on Monday, reaching $290.17. The stock had a trading volume of 650,832 shares, compared to its average volume of 687,699. The stock has a market cap of $15.73 billion, a PE ratio of 14.20, a P/E/G ratio of 1.06 and a beta of 0.56. Molina Healthcare, Inc. has a one year low of $262.32 and a one year high of $365.23. The firm's 50 day moving average price is $316.10 and its two-hundred day moving average price is $307.35. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, beating the consensus estimate of $5.96 by $0.12. The company had revenue of $11.15 billion during the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The business's revenue was up 12.2% compared to the same quarter last year. During the same period in the prior year, the company earned $5.73 earnings per share. On average, research analysts forecast that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Guggenheim initiated coverage on shares of Molina Healthcare in a research note on Wednesday, April 9th. They set a "neutral" rating for the company. Truist Financial upped their price target on shares of Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a research report on Friday, April 11th. Wells Fargo & Company raised Molina Healthcare from an "equal weight" rating to an "overweight" rating and raised their price objective for the company from $295.00 to $372.00 in a research report on Wednesday, March 5th. Wall Street Zen raised Molina Healthcare from a "hold" rating to a "buy" rating in a research report on Friday, April 11th. Finally, Baird R W downgraded Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Nine equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $364.21.

View Our Latest Stock Report on MOH

Insiders Place Their Bets

In related news, Director Richard M. Schapiro sold 669 shares of the company's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the completion of the sale, the director now owns 11,244 shares of the company's stock, valued at $3,603,702. This represents a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the business's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the sale, the chief executive officer now owns 257,715 shares in the company, valued at $82,484,262.90. This trade represents a 25.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.10% of the stock is owned by insiders.

About Molina Healthcare

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Read More

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines